![](https://investorshub.advfn.com/uicon/373583.png?cb=1492766821)
Tuesday, April 26, 2016 8:40:52 AM
PPCH is on the veryge of Phase I human trials for cancer with their lead product PRP that has shown a high degree of efficasy in treatment of solid tumors such as pancreatic, ovarian and colorectal cancers . In addition, "The Company is soon to meet with the MHRA (Medicines and Healthcare Products Regulatory Agency) to discuss formal preclinical and clinical development activities for PRP." In addition PPCH has announced they intend to apply for Orphan Drug designation in both the US and EU very soon.
By the volume we've seen, and are seeing, I'd say people are taking this quite seriously. HUGE potential!!
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM